View Single Post
Old 06-15-2007, 02:33 PM   #5
CLTann
Senior Member
 
Join Date: Oct 2005
Posts: 476
I have always suspected that oncologists are making excessive money in their office chemo settings. This is obviously an area FDA should investigate and police. Drug makers too should be held accountable for their reasonable profit and research.
__________________
Ann

Stage 1 dx Sept 05
ER/PR positive HER2 +++ Grade 3
Invasive carcinoma 1 cm, no node involvement
Mastec Sept 05
Annual scans all negative, Oct 06
Postmenopause. Arimidex only since Sept 06, bone or muscle ache after 3 month
Off Arimidex, change to Femara 1/12-07, ache stopped
Sept 07 all tests negative, pass 2 year mark
Feb 08 continue doing well.
Sep 09 four year NED still on Femara.
CLTann is offline   Reply With Quote